Aldeyra Therapeutics, Inc. (ALDX)
Last updated: 2026-10-21 16:24:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Aldeyra Therapeutics, Inc. (ALDX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.71, with a market capitalization of $40.12M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.65 to $5.93. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$40.12M | |
$0.74 | |
$16.70 | |
$0.65 | |
$0.73 | |
188.46K | |
1.18M | |
-- | |
$5.93 | |
$0.65 | |
-- | |
-- |
Aldeyra Therapeutics, Inc. (ALDX) Stock Price Today
Aldeyra Therapeutics, Inc. (ALDX) is currently trading at $0.71 as of 2026-10-21 16:23:00, down 3.72% ($0.03) from the previous close of $0.73
During today's regular trading session, ALDX has traded between $0.65 and $16.70, with a trading volume of 188.46K shares. The current price is near the lower end of today's range.
Aldeyra Therapeutics, Inc. (ALDX) 7-Day Stock Price Change
Over the past seven days, Aldeyra Therapeutics, Inc. (ALDX) moved from $0.91 to $0.71, representing a decline of 21.95% ($0.20).
The stock traded between $0.65 and $0.94 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.42 million shares, down versus the previous seven-day period, indicating lower trading activity.
ALDX 52-Week Price Position
Position in Range: 1.1%
ALDX is currently trading at $0.71, placing it 1.1% of the way from its 52-week low of $0.65 to its 52-week high of $5.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Aldeyra Therapeutics, Inc. (ALDX)?
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Aldeyra Therapeutics, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Aldeyra Therapeutics, Inc. (ALDX) Stock on MEXC
Eligible investors can buy real shares of Aldeyra Therapeutics, Inc. (ALDX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Aldeyra Therapeutics, Inc. (ALDX) stock price today?
2.Is ALDX stock going up or down today?
3.What is ALDX pre-market price?
4.What is ALDX after-hours price?
5.Is ALDX stock trading now?
6.Where does ALDX sit relative to its 52-week high and low?
7.What sector is Aldeyra Therapeutics, Inc. in?
8.What is Aldeyra Therapeutics, Inc.'s market capitalization and where is it listed?
9.How is ALDX valued in terms of P/E ratio and EPS?
10.Does Aldeyra Therapeutics, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
ALDX Stock Calculator
Estimate the value between ALDX shares and USD.
ALDX Shares to USD
1.00 ALDX shares = 0.707 USD
Calculations are estimates based on the latest available price and are for reference only.


